Market Research Logo

Australia Market Report for Uterine Fibroid Embolization Devices 2017 - MedCore

Australia Market Report for Uterine Fibroid Embolization Devices 2017 - MedCore

Endometrial resection offers an alternative treatment option to a hysterectomy for the treatment of menorrhagia (heavy bleeding). Heavy bleeding is sometimes referred to as 80mL or more per menstrual cycle, which can interfere with a woman’s daily life. Endometrial resection is performed as hysteroscopic procedure to remove the endometrial lining using a resectoscope and an electrosurgical loop electrode. Endometrial resection is appropriate for women who have pure menorrhagia but no other additional abnormalities, such as endometriosis, endometrial hyperplasia or very large or rapidly growing fibroids. Many patients of endometrial resection, in addition to having a reduction of menorrhagia symptoms, also experience a reduction in other symptoms related to premenstrual syndrome (PMS).


EXECUTIVE SUMMARY
1.1 AUSTRALIA MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW
1.2 COMPETITIVE ANALYSIS
1.3 MARKET TRENDS
1.4 MARKET DEVELOPMENTS
1.5 PROCEDURE NUMBERS
1.6 MARKETS INCLUDED
1.7 KEY REPORT UPDATES
1.8 VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics
2.2.3 Indications for Assisted Reproduction Technologies (ART)
2.2.3.1 ART cost: coverage policy and medical insurance in different countries
2.2.4 Abnormal Uterine Bleeding
2.2.5 Gynecologic Cancer and Tumors in Reproductive System
2.2.6 Indications for Female Sterilization
2.2.7 Urinary Incontinence
2.2.8 Indications for Pelvic Organ Prolapse Repair
2.2.9 Indications for CO2 Fractional Laser
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Uterine Fibroid Embolization
3.1.1.1 Introduction
3.1.1.2 Microspheres
3.1.1.3 Polyvinyl Alcohol Particles
3.1.1.4 Drug-eluting Particles
3.1.1.5 Product Matrix for Uterine Fibroid Embolization
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Uterine Fibroid Embolization
3.3 CLINICAL TRIALS
3.3.1 Uterine Fibroid Embolization
UTERINE FIBROID EMBOLIZATION DEVICE MARKET
4.1 INTRODUCTION
4.1.1 Microspheres
4.1.2 Polyvinyl Alcohol Particles
4.1.3 Drug-eluting Particles
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Uterine Fibroid Embolization Device Market
4.3.2 Microsphere Market
4.3.3 PVA Particle Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX II: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Gynecological Device Market by Segment, Australia, 2013 – 2023
Chart 1 2: Gynecological Device Market by Segment, Australia, 2016 & 2023
Chart 4 1: Uterine Fibroid Embolization Device Market by Segment, Australia, 2013 – 2023
Chart 4 2: Uterine Fibroid Embolization Device Market Breakdown, Australia, 2016
Chart 4 3: Uterine Fibroid Embolization Device Market Breakdown, Australia, 2023
Chart 4 4: Total Uterine Fibroid Embolization Device Market, Australia, 2013 – 2023
Chart 4 5: Microsphere Market, Australia, 2013 – 2023
Chart 4 6: PVA Particle Market, Australia, 2013 – 2023
Chart 4 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Australia, 2016
List of Figures
Figure 1 1: Gynecological Device Market by Segment, Australia, 2016 (1 of 2)
Figure 1 2: Gynecological Device Market by Segment, Australia, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Australia, 2016
Figure 1 4: Factors Impacting the Gynecological Device Market by Segment, Australia (1 of 2)
Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Australia (2 of 2)
Figure 1 6: Recent Events in the Gynecological Device Market, Australia, 2012 – 2016
Figure 1 7: Gynecological Procedure Numbers Covered, Australia, 2016
Figure 1 8: Gynecological Device Markets Covered, Australia, 2016
Figure 1 9: Key Report Updates
Figure 1 10: Version History
Figure 2 1: Gynecological Disease Overview
Figure 2 2: ART Procedure Availability Overview
Figure 2 3: ART Procedure Availability Overview
Figure 3 1: Class 2 Device Recall: SpermMar Test
Figure 3 2: Uterine Fibroid Embolization: Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization
Figure 3 3: Uterine Fibroid Embolization: Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Figure 4 1: Uterine Fibroid Embolization Device Market by Segment, Australia, 2013 – 2023 (AU$M)
Figure 4 2: Uterine Fibroid Embolization Device Market by Segment, Australia, 2013 – 2023 (US$M)
Figure 4 3: Total Uterine Fibroid Embolization Device Market, Australia, 2013 – 2023
Figure 4 4: Microsphere Market, Australia, 2013 – 2023
Figure 4 5: PVA Particle Market, Australia, 2013 – 2023
Figure 4 6: Drivers and Limiters, Uterine Fibroid Embolization Device Market, Australia, 2016
Figure 4 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Australia, 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report